ATE429250T1 - Mittel zur behandlung der allergischen kontaktdermatitis - Google Patents
Mittel zur behandlung der allergischen kontaktdermatitisInfo
- Publication number
- ATE429250T1 ATE429250T1 AT04713978T AT04713978T ATE429250T1 AT E429250 T1 ATE429250 T1 AT E429250T1 AT 04713978 T AT04713978 T AT 04713978T AT 04713978 T AT04713978 T AT 04713978T AT E429250 T1 ATE429250 T1 AT E429250T1
- Authority
- AT
- Austria
- Prior art keywords
- contact dermatitis
- allergic contact
- agents
- treatment
- remedy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Devices For Medical Bathing And Washing (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44975203P | 2003-02-26 | 2003-02-26 | |
PCT/JP2004/002114 WO2004075915A1 (ja) | 2003-02-26 | 2004-02-24 | アレルギー性接触性皮膚炎治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429250T1 true ATE429250T1 (de) | 2009-05-15 |
Family
ID=32927559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04713978T ATE429250T1 (de) | 2003-02-26 | 2004-02-24 | Mittel zur behandlung der allergischen kontaktdermatitis |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060140872A1 (de) |
EP (1) | EP1598079B1 (de) |
JP (1) | JPWO2004075915A1 (de) |
AT (1) | ATE429250T1 (de) |
DE (1) | DE602004020741D1 (de) |
ES (1) | ES2324165T3 (de) |
WO (1) | WO2004075915A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1912636T3 (pl) | 2005-07-21 | 2015-02-27 | Ardea Biosciences Inc | N-(aryloamino)sulfonamidowe inhibitory mek |
US8101799B2 (en) * | 2005-07-21 | 2012-01-24 | Ardea Biosciences | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK |
ES2597052T3 (es) * | 2011-05-25 | 2017-01-13 | Université Paris Descartes | Inhibidores de ERK para su uso en el tratamiento de atrofia muscular espinal |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5525625A (en) * | 1995-01-24 | 1996-06-11 | Warner-Lambert Company | 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders |
WO1999061440A1 (en) * | 1998-05-26 | 1999-12-02 | Smithkline Beecham Corporation | Novel substituted imidazole compounds |
AU2002310441A1 (en) * | 2001-06-14 | 2003-01-02 | The Regents Of The University Of California | A novel signaling pathway for the production of inflammatory pain and neuropathy |
EP2275102B1 (de) * | 2002-03-13 | 2015-07-29 | Array Biopharma, Inc. | N3-alkylierte Benzimidazolderivate als MEK-Inhibitoren |
-
2004
- 2004-02-24 EP EP04713978A patent/EP1598079B1/de not_active Expired - Lifetime
- 2004-02-24 AT AT04713978T patent/ATE429250T1/de not_active IP Right Cessation
- 2004-02-24 WO PCT/JP2004/002114 patent/WO2004075915A1/ja active Application Filing
- 2004-02-24 DE DE602004020741T patent/DE602004020741D1/de not_active Expired - Lifetime
- 2004-02-24 JP JP2005502879A patent/JPWO2004075915A1/ja active Pending
- 2004-02-24 US US10/545,085 patent/US20060140872A1/en not_active Abandoned
- 2004-02-24 ES ES04713978T patent/ES2324165T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1598079B1 (de) | 2009-04-22 |
US20060140872A1 (en) | 2006-06-29 |
JPWO2004075915A1 (ja) | 2006-06-01 |
WO2004075915A1 (ja) | 2004-09-10 |
DE602004020741D1 (de) | 2009-06-04 |
EP1598079A1 (de) | 2005-11-23 |
EP1598079A4 (de) | 2006-03-22 |
ES2324165T3 (es) | 2009-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607017A2 (pt) | métodos e composições para o tratamento de condições relacionadas ao snc | |
ATE492542T1 (de) | Herstellung und anwendung von biphenyl-4-yl- carbonylaminosäurederivaten zur behandlung von obesitas | |
ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE405840T1 (de) | Zusammensetzungen und verfahren zur stabilisierung von transthyretin und zur hemmung von transthyretin-fehlfaltung | |
ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
NO20063064L (no) | Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte | |
ATE524479T1 (de) | Sulfonamidthiazolpyridinderivate als zur behandlung von typ-2-diabetes geeignete glucokinaseaktivatoren | |
ATE515261T1 (de) | Zusammensetzungen zur behandlung von diabetes | |
ATE368031T1 (de) | Neue gamma secretase inhibitoren | |
DE602004014296D1 (de) | Chromfreies Mittel zur Behandlung von Metalloberflächen | |
ATE446754T1 (de) | Verbindungen zur behandlung von schizophrenie und/oder glucoregulatorische auffälligkeiten | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
ATE489948T1 (de) | Behandlung von autoimmunkrankheiten | |
DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
ATE369130T1 (de) | Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen | |
ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
DE60333205D1 (de) | Histaminika zur behandlung von allergischer rhinitis | |
ATE345340T1 (de) | N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis | |
DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
EA200701584A1 (ru) | Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения | |
ATE429250T1 (de) | Mittel zur behandlung der allergischen kontaktdermatitis | |
ATE457725T1 (de) | Kynurenine 3-hydroxylase inhibitoren zur behandlung von diabetes | |
DE60231994D1 (de) | Mittel zur behandlung oder prävention allergischerg | |
ATE389439T1 (de) | Behandlung von einschlusskörper-myositis | |
EA200702479A1 (ru) | Активная композиция для лечения и профилактики расстройств, связанных с нарушением работы биологических часов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |